Therefore, ESAs are not indicated for use in oncology patients with CKD who are receiving
myelosuppressive therapy if the intent is to cure the patient.
A randomized, non-inferiority study of recombinant human G-CSF/human serum albumin fusion (CG-10639) and pegfilgrastim in breast cancer patients receiving
myelosuppressive therapy.
Treatment strategies include using bland rinses for mild to moderate oral mucositis pain, topical anesthetics, and prophylactic antiviral and antifungal therapy in patients undergoing
myelosuppressive therapy to prevent infections that can aggravate oral mucositis.
Plasma erythropoietin concentrations in polycythaemia vera with special reference to
myelosuppressive therapy. Leuk Lymphoma 2000;37: 189-95.
Patients administered mildly
myelosuppressive therapy are at low risk.
